Capital Bank & Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Capital Bank & Trust's PFE Position: Q2 2021 in Review
Capital Bank & Trust sold out of Pfizer (PFE) in Q2 2021, closing a stake of 54,865 shares — an estimated $1.99M sold.
Capital Bank & Trust first reported a position in PFE in Q2 2017 and held it in 16 quarters. The position peaked at $12.6M in Q3 2018. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.
- Capital Bank & Trust reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
- Capital Bank & Trust sold 54,865 Pfizer shares in Q2 2021, an estimated $1.99M.
- Capital Bank & Trust first reported a position in Pfizer in Q2 2017 and held it in 16 quarters.
- Capital Bank & Trust's Pfizer position peaked at $12.6M in Q3 2018.
- 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.
Based on Capital Bank & Trust's 13F filing for Q2 2021, filed 16 Aug 2021.